Funding for this research was provided by:
National Institute of General Medical Sciences of the National Institutes of Health (U54GM104938)
Oklahoma Center for the Advancement of Science and Technology (HR14-147)
American Cancer Society (CNE-117557)
Text and Data Mining valid from 2018-10-26
Received: 12 April 2018
Accepted: 12 October 2018
First Online: 26 October 2018
Ethics approval and consent to participate
: Athymic nude mice (Foxn1nu) were purchased from Envigo (United Kingdom) and were used for in vivo evaluation of Sorafenib and DHA in accordance with the Institute Animal Care and Use Committee procedures and guidelines (Institute IACUC Protocol 100,861–14-025-SSH). All human cell lines were approved for use in this study by the Institutional Review Board (IRB protocol 4381).
: Not applicable.
: The authors have no competing interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.